Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.07 USD | +2.01% | +10.41% | +43.84% |
03-28 | Transcript : Humacyte, Inc. - Special Call | |
03-22 | Transcript : Humacyte, Inc., Q4 2023 Earnings Call, Mar 22, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.84% | 475M | |
+1.46% | 42.75B | |
+47.70% | 41.61B | |
+12.10% | 41.34B | |
-8.83% | 26.59B | |
+6.96% | 25.49B | |
-23.03% | 18.12B | |
+29.96% | 12.24B | |
-2.31% | 11.76B | |
+8.37% | 11B |
- Stock Market
- Equities
- HUMA Stock
- News Humacyte, Inc.
- Piper Sandler Double Downgrades Humacyte to Underweight From Overweight, Adjusts Price Target to $4 From $10